{"id":3089,"date":"2009-12-22T01:45:16","date_gmt":"2009-12-22T06:45:16","guid":{"rendered":"http:\/\/gillesenvrac.ca\/carnet\/?p=3089"},"modified":"2009-12-22T01:45:16","modified_gmt":"2009-12-22T06:45:16","slug":"tamiflu","status":"publish","type":"post","link":"https:\/\/gillesenvrac.ca\/carnet\/2009\/12\/tamiflu\/","title":{"rendered":"Tamiflu et l'acc\u00e8s aux donn\u00e9es de recherche"},"content":{"rendered":"

Complications: tracking down the data on oseltamivir<\/a>. Cet article (en acc\u00e8s libre) de la revue British Medical Journal<\/strong><\/span> raconte dans le d\u00e9tail les difficult\u00e9s \u00e0 obtenir des r\u00e9ponses de la part de la pharmaceutique Roche, \u00e0 propos d’un ensemble de recherches suppos\u00e9es confirmer la pertinence et l’efficacit\u00e9 du Tamiflu (oseltamivir, de son nom g\u00e9n\u00e9rique) pour diminuer les complications de l’influenza. Chose inhabituelle, m\u00eame l’\u00e9ditorial est en acc\u00e8s libre, dans ce num\u00e9ro. Il appelle \u00e0 rendre les donn\u00e9es publiques : Why don\u2019t we have all the evidence on oseltamivir?<\/a> The full data from drug trials must be available for scrutiny by the scientific community<\/em>.<\/p>\n

Although billions have been spent on oseltamivir in the face <\/sup>of pandemic influenza, the team updating the Cochrane review <\/sup>of neuraminidase inhibitors in healthy adults found that the <\/sup>public evidence base for this global public health drug was <\/sup>fragmented and inconsistent.<\/p><\/blockquote>\n

L’article faisant \u00e9tat de l’\u00e9valuation syst\u00e9matique par m\u00e9ta-analyse est lui aussi en acc\u00e8s libre : Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis<\/a>. Ces articles sont parus dans le num\u00e9ro du 12 d\u00e9cembre du BMJ<\/a>.<\/p>\n

La d\u00e9marche men\u00e9e par les chercheurs et journalistes du BMJ (et aussi d’un canal de t\u00e9l\u00e9vision<\/a> britannique) ont amen\u00e9 la publication (partielle) des r\u00e9sultats de la part de Roche : http:\/\/roche-trials.com\/<\/p>\n","protected":false},"excerpt":{"rendered":"

Complications: tracking down the data on oseltamivir. Cet article (en acc\u00e8s libre) de la revue British Medical Journal raconte dans le d\u00e9tail les difficult\u00e9s \u00e0 obtenir des r\u00e9ponses de la part de la pharmaceutique Roche, \u00e0 propos d’un ensemble de recherches suppos\u00e9es confirmer la pertinence et l’efficacit\u00e9 du Tamiflu (oseltamivir, de son nom g\u00e9n\u00e9rique) pour … <\/p>\n

Continuer la lecture de « Tamiflu et l'acc\u00e8s aux donn\u00e9es de recherche »<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"atmosphere_disabled":false,"atmosphere_custom_text":"","_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[],"tags":[151,153],"class_list":["post-3089","post","type-post","status-publish","format-standard","hentry","tag-sante-publique","tag-sciences"],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":3730,"url":"https:\/\/gillesenvrac.ca\/carnet\/2011\/03\/donnees-ouvertes\/","url_meta":{"origin":3089,"position":0},"title":"donn\u00e9es publiques ouvertes","author":"Gilles Beauchamp","date":"9 mars 2011","format":false,"excerpt":"Un rapport europ\u00e9en fait le point sur l'acc\u00e8s aux donn\u00e9es publiques dans 9 pays d'Europe : UNCHARTERED WATERS\u00a0\u2013 The State of Open Data in Europe (janvier 2011, 37 p.). Dans le m\u00eame ordre d'id\u00e9e : Open Government Data in Europe, une publication de The Open Data Fpoundation (septembre 2010, 52\u2026","rel":"","context":"Dans \"acc\u00e8s libre\"","block_context":{"text":"acc\u00e8s libre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/acces-libre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":630,"url":"https:\/\/gillesenvrac.ca\/carnet\/2007\/09\/subventions-acces-libre-aux-resultats\/","url_meta":{"origin":3089,"position":1},"title":"subventions = acc\u00e8s libre aux r\u00e9sultats","author":"Gilles Beauchamp","date":"6 septembre 2007","format":false,"excerpt":"CIHR Introduces New Open Access Policy: \"The Canadian Institute for Health Research has announced, formally, its Open Access mandate for all funded research. Peter Suber has coverage. Stevan Harnad notes that it makes CIHR the 31st organization worldwide to do so. It's worth noting that this amounts to 'five percent\u2026","rel":"","context":"Dans \"droits d'auteur\"","block_context":{"text":"droits d'auteur","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/droits-dauteur\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3696,"url":"https:\/\/gillesenvrac.ca\/carnet\/2011\/02\/samedi-libre\/","url_meta":{"origin":3089,"position":2},"title":"samedi libre","author":"Gilles Beauchamp","date":"19 f\u00e9vrier 2011","format":false,"excerpt":"Libre comme datalibre.ca, o\u00f9 j'ai trouv\u00e9 cette Soumission au Comit\u00e9 permanent d'acc\u00e8s \u00e0 l'information du parlement f\u00e9d\u00e9ral. Un document qui vaut non seulement pour sa promotion argument\u00e9e d'un \"gouvernement transparent\" mais aussi pour la liste impressionnante des sites et ressources cit\u00e9s. J'y d\u00e9couvre ou red\u00e9couvre, notamment... les Rapports produits par\u2026","rel":"","context":"Dans \"acc\u00e8s libre\"","block_context":{"text":"acc\u00e8s libre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/acces-libre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":186,"url":"https:\/\/gillesenvrac.ca\/carnet\/2005\/09\/lacces-libre-une-condition\/","url_meta":{"origin":3089,"position":3},"title":"l'acc\u00e8s libre : une condition","author":"Gilles Beauchamp","date":"13 septembre 2005","format":false,"excerpt":"Call for Free Access to Research , BBC News\u00a0More on what is becoming a pervasive trend, the call for free access to publicly funded research. \"The eight UK research councils, which control most of the public funding, have proposed making free access a condition of getting grants.\"\u00a0 [OLDaily] Huit conseils\u2026","rel":"","context":"Dans \"acc\u00e8s libre\"","block_context":{"text":"acc\u00e8s libre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/acces-libre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1806,"url":"https:\/\/gillesenvrac.ca\/carnet\/2009\/01\/acces-libre-a-oxford\/","url_meta":{"origin":3089,"position":4},"title":"acc\u00e8s libre \u00e0 Oxford","author":"Gilles Beauchamp","date":"28 janvier 2009","format":false,"excerpt":"International Journal of Epidemiology Journal of Public Health European Journal of Public Health Health Education Research British Journal of Social Work Analysis Mind Social History of Medicine Age and Ageing Je ne sais si \u00e7a durera longtemps... mais j'ai pu obtenir tous les articles que j'ai voulus de ces revues,\u2026","rel":"","context":"Dans \"acc\u00e8s libre\"","block_context":{"text":"acc\u00e8s libre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/acces-libre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":6271,"url":"https:\/\/gillesenvrac.ca\/carnet\/2020\/03\/entraide-corona\/","url_meta":{"origin":3089,"position":5},"title":"L\u2019entraide au temps du corona*","author":"Gilles Beauchamp","date":"24 mars 2020","format":false,"excerpt":"Journaux et revues en acc\u00e8s libre Le British Medical Journal donne acc\u00e8s gratuit \u00e0 tous ses articles relatifs au COVID-19. L\u2019importante revue m\u00e9dicale donne d\u00e9j\u00e0 acc\u00e8s libre en temps normal aux articles de r\u00e9sultats de recherche. S\u2019ajoutent donc les articles plus conjoncturels sur l\u2019actuelle pand\u00e9mie. D\u2019autres revues et journaux ont\u2026","rel":"","context":"Dans \"#covid-19\"","block_context":{"text":"#covid-19","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/posts\/3089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/comments?post=3089"}],"version-history":[{"count":0,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/posts\/3089\/revisions"}],"wp:attachment":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/media?parent=3089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/categories?post=3089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/tags?post=3089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}